Immediate Impact
75 standout
Citing Papers
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
2025 Standout
Prostate Cancer
2025 Standout
Works of Tetsuro Ito being referenced
Survival benefit, disease progression and quality-of-life outcomes of abiraterone acetate plus prednisone versus docetaxel in metastatic hormone-sensitive prostate cancer: A network meta-analysis
2018
Indirect comparison of abiraterone acetate and docetaxel for treatment of metastatic “hormone-sensitive” prostate cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tetsuro Ito | 101 | 59 | 54 | 75 | 32 | 360 | |
| Xiaojin Liu | 69 | 41 | 10 | 14 | 22 | 354 | |
| James Kurtz | 37 | 83 | 127 | 12 | 24 | 375 | |
| Wei Xu | 49 | 54 | 63 | 11 | 25 | 378 | |
| T. Okano | 24 | 42 | 52 | 12 | 36 | 406 | |
| Tsuguru Hayashi | 67 | 50 | 20 | 23 | 29 | 375 | |
| Jing He | 84 | 19 | 10 | 42 | 35 | 333 | |
| Marjolein Lahaye | 64 | 26 | 8 | 36 | 49 | 409 | |
| Eliezer Liberman | 49 | 77 | 14 | 79 | 30 | 347 | |
| Marta Ballanti | 23 | 17 | 24 | 14 | 16 | 351 | |
| Thomas | 71 | 24 | 31 | 8 | 21 | 311 |
All Works
Login with ORCID to disown or claim papers
Loading papers...